| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/20/2006 | EP1432792B1 Histone deacetylase 9 |
| 09/20/2006 | EP1299135B1 Wound dressing comprising terrilytin as therapeutically active agent |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP1261365B1 Product for biological anchoring of connective tissue to bone |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1079875B1 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 09/20/2006 | EP1051191B1 CD154 BLOCKADE THERAPY FOR PANCREATIC ISLET TISSUE TRANSPLANTATION in primates |
| 09/20/2006 | EP1003577B1 Blood product delivery system |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/20/2006 | EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 09/20/2006 | CN1836048A Transducible DNA-binding proteins |
| 09/20/2006 | CN1836042A Conserved HBV and HCV sequences useful for gene silencing |
| 09/20/2006 | CN1835970A Peptides enhancing CEH activity or ACAT inhibitory activity, pharmaceutical compositions comrising these peptides and their use in the treatment of atherosclerosis |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835911A Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
| 09/20/2006 | CN1835792A Injectable hydrogel microspheres from aqueous two-phase system |
| 09/20/2006 | CN1835769A KIM-1 antagonists and use to modulate immune system |
| 09/20/2006 | CN1835766A Osteogenesis promoter |
| 09/20/2006 | CN1835765A Method of treating viral infections |
| 09/20/2006 | CN1835764A Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure |
| 09/20/2006 | CN1835763A CCN1 compositions and methods |
| 09/20/2006 | CN1835755A Gsk－3抑制剂及其用途 Gsk-3 inhibitors and their use |
| 09/20/2006 | CN1834239A Prepn. process for freezing dry powder of bromelain |
| 09/20/2006 | CN1834238A Prepn. process of and use of thrombus dissolving enzyme |
| 09/20/2006 | CN1834107A Recombination human A20 protein and its uses |
| 09/20/2006 | CN1834088A Tetrapeptide derivative crystals |
| 09/20/2006 | CN1833722A Health products for face care and body care |
| 09/20/2006 | CN1833721A Compsns. of thymopentin and interferon |
| 09/20/2006 | CN1833720A Biological answer-reply regulator of microbe extracting factor |
| 09/20/2006 | CN1276084C Long-noded pit viper poison dissolving fiber protein No.8 gene and use thereof |
| 09/20/2006 | CN1276079C Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 09/20/2006 | CN1275981C Method of monomerizing human serum albumin polymers |
| 09/20/2006 | CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275647C Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 09/20/2006 | CN1275646C Nose drops of recombined human interferon alpha 2b and preparing method |
| 09/20/2006 | CN1275645C Changsanye-factor oral liquor and clinical use |
| 09/20/2006 | CN1275644C Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication |
| 09/20/2006 | CN1275643C Short peptide type nutriend emulsion inside bowel and producing method |
| 09/19/2006 | USRE39299 INGAP protein involved in pancreatic islet neogenesis |
| 09/19/2006 | US7109397 Comprises nucleotide sequences coding hypersensitive response elicitor protein (HREP) for conferring improved ripening, flowering, longevity and disease, stress and dessication resistance to plants; biological pest control |
| 09/19/2006 | US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109319 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/19/2006 | US7109308 Inhibiting tumor growth, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis; diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein |
| 09/19/2006 | US7109307 Nucleotide sequences coding polypeptide for use in the treatent of inflammatory disorders |
| 09/19/2006 | US7109306 Antibody or fragment that specifically binds to a protein, decrease in the level of mim-1 protein is observed; inhibiting abnormal cell proliferation or differentiation |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109300 Treating fish skin with scales, alligator skeleton, chicken skeleton, turkey skeleton, crustaceans with an aqueous alkali solution, then ethanol, rinsing then disolving the collagen with acid and pepsin; dissolving and precipitating the collagen; no prior decalcification step, does not require EDTA |
| 09/19/2006 | US7109299 Peptides of sequence of amino acids where one or more of the peptidyl [ C(O)NR ] linkages (bonds) have been replaced by a non-peptidyl linkage; IL-5 antagonists treating asthma |
| 09/19/2006 | US7109298 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in an HT-29 colon carcinoma cell |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109172 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109170 Tetra-, penta-, hexa-, hepta-, octa-, or nonapeptide capable of inhibiting the activation of blood-coagulation factor X in presence of coagulation factor VIIIa; polypeptide derived from helix 330 of blood coagulation factor IXa |
| 09/19/2006 | US7109169 Results in correction of cellular calcium handling and enhancement of cardiac contractility to healthy levels. This method can be used for treatment of acute heart failure, cardiogenic shock and congestive heart failure. |
| 09/19/2006 | US7109168 Neurotrophic peptides exhibiting increased metabolic stability while retaining biological activity |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7109166 A piperazine-somatostatin analog in sustained release ionic conjugate with lactic acid-glycolic acid-tartaric acid copolymer; for therapy of gastrointestinal disorders, such as Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis |
| 09/19/2006 | US7109165 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109163 For use in hemostatic devices that are suitable for applying a flowable hemostatic formulation to a site requiring hemostasis |
| 09/19/2006 | US7109161 Benzethonium chloride in combination with phenoxyethanol; antimicrobial |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/19/2006 | US7109159 Administering to a mammal an active agent selected from the group consisting of leptin; a mutein of leptin fusion protein, fusion protein for inhibiting tumor cell proliferation in mammals |
| 09/19/2006 | US7109030 Anticarcinogenic, antiproliferative agents; drug screening, receptor binding assay |
| 09/19/2006 | US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7109017 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
| 09/19/2006 | US7109006 Virulence of Streptococci |
| 09/19/2006 | US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma |
| 09/19/2006 | US7109000 Isolated polypeptide of given sequence; use in diagnosis and treatment of cardiomyopathy, atherosclerosis, cancer and diabetes |
| 09/19/2006 | US7108999 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 09/19/2006 | US7108995 Small peptides having apoptotic activities and their applications |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108972 Proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2006 | US7108869 For limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual |
| 09/19/2006 | US7108867 Process for preparing particles |
| 09/19/2006 | US7108857 Therapy for injured muscles |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/19/2006 | US7108851 In a subject suffering from a disorder characterized by increased cell proliferation or by co-infection with mycoplasma and a second microbe; administering an agent that prevents sialic acid- mediated attachment of mycoplasma cells |
| 09/19/2006 | US7108850 Polypeptides of an IL-1-like cytokine |
| 09/19/2006 | CA2238352C Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/14/2006 | WO2006096847A1 Obestatin and its uses |
| 09/14/2006 | WO2006096829A2 Thyrotropin-releasing hormone analogs and method of use |
| 09/14/2006 | WO2006096774A2 Composition and methods for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers |
| 09/14/2006 | WO2006096757A2 Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens |
| 09/14/2006 | WO2006096690A2 Compositions and methods for inhibiting g protein signaling |
| 09/14/2006 | WO2006096614A2 Angiogenic heparin binding peptide amphiphiles |
| 09/14/2006 | WO2006096565A2 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |